Target intelligence / Profile preview

Mugwort pollen allergen (Art v (component name, e.g., Art v 1, Art v 3))

Target
Art v (component name, e.g., Art v 1, Art v 3)
Molecular classification
Other (pollen protein allergens; component proteins include defensin-like protein, non-specific lipid transfer protein, profilin, polcalcin, pectate lyase, PR-1 protein)
01

Overview

Mugwort pollen allergens are a complex mixture of proteins derived from the pollen of **Artemisia vulgaris** (mugwort), a weed from the family *Asteraceae* (Compositae)[1][3]. The major clinically relevant molecules are **Art v 1** (defensin-like protein) and **Art v 3** (non-specific lipid transfer protein), among others (Art v 2, Art v 4, Art v 5, Art v 6)[1][2]. These proteins are recognized by IgE antibodies in genetically predisposed individuals and trigger type I hypersensitivity reactions, causing symptoms such as allergic rhinitis, conjunctivitis, asthma, and sometimes systemic reactions (pollen allergy and pollen-food allergy syndrome)[1][2][3]. Pollen-derived allergens exhibit extensive cross-reactivity with other members of the *Asteraceae* family (e.g., ragweed), and can cause food allergies due to structurally similar allergens in foods (e.g. celery, peach, mustard)[1][2]. The dominant protein responsible for respiratory symptoms is Art v 1, while Art v 3 is significant for cross-reactive food allergy syndromes[1][2]. Mugwort pollen is not a single therapeutic target, but a source of multiple functionally unrelated protein allergens, and "allergens from mugwort pollen" is a category, not a molecule.

Other names
Artemisia vulgaris pollen allergenmugwort pollenArt v allergenscommon wormwood allergenwild wormwood allergenfelon herb pollen allergen
02

Mechanism of action

Drugs used for allergy block IgE binding to allergens, dampen allergic inflammation, or desensitize the immune system to allergens (immunotherapy)

03

Biological functions

Immune response (IgE-mediated hypersensitivity, allergenicity)
04

Disease associations

Inflammationallergyasthmaallergic rhinitisallergic conjunctivitisoral allergy syndromepollen-food allergy syndrome
05

Safety considerations

High allergenic potentialrisk of anaphylaxis and severe asthma in sensitized individualsrisk of cross-reactivity with foods (oral allergy syndrome and pollen-food allergy syndrome)[1][2][3]
06

Interacting drugs

Allergen immunotherapy extracts (pollens)

1 more in the full profile.

07

Biomarkers

Specific IgE to Art v 1, Art v 3skin prick test with mugwort pollen extractArt v 3 is used as a biomarker for cross-reactive pollen-food allergy syndrome[1][2]

Beyond the preview

Go deeper on Mugwort pollen allergen (Art v (component name, e.g., Art v 1, Art v 3)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mugwort pollen allergen (Art v (component name, e.g., Art v 1, Art v 3)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call